Not Signed In - All Topic Areas
1 - 10 of 11 more >>
Clinical Trials
1 - 5 of 22 more >>
- Study of the Farnesyl Transferase Inhibitor, R115777, in Combination with Topotecan (NYU 99-32)
ClinicalTrials.gov Identifier: NCT00006199 - Recruiting
Cancer
- R115777 to Treat Children with Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
ClinicalTrials.gov Identifier: NCT00021541 - Recruiting
Neurofibroma, Plexiform; Neurofibromatosis Type I
- Trastuzumab Plus R115777 in Treating Patients with Advanced or Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00005842 - Completed
Cancer
- R115777 in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00021203 - Active, not recruiting
stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Gemcitabine With or Without R115777 in Treating Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00005648 - Active, not recruiting
recurrent pancreatic cancer; stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; ...
email this page
print this page
bookmark this page
feedback on this page
